SREBF1 and metabolic dysfunction-associated steatotic liver disease: These results are in agreement with a previous study showing that, in the liver of obese patients with NAFLD, the PPAR-γ is up-regulated, demonstrating an additional lipogenic mechanism to SREBP-1c induction on the development of hepatic steatosis (Pettinelli et al., 2011[25]).